Life Sciences 2026

POLAND Trends and Developments

Trends and Developments Contributed by: Marta Sroka-Maleta, Andrzej Siwiec, Katarzyna Kroner and Maciej Adamczyk DBS Law Firm

DBS Law Firm is a boutique law firm that has been active for more than two decades. It is dedicated ex- clusively to advising the life sciences and healthcare sector, and its 15-lawyer team offers trusted guid- ance to clients on core activities such as regulatory, reimbursement, advertising, distribution, manufac- turing and business development projects. It assists with pharmaceutical, medical devices, food, cosmet- ic and reimbursement law matters, while also advis- ing healthcare providers. The firm helps to create and develop European and Polish laws regulating various

key issues for the life sciences sector. Its experts are invited to participate in drafting legislative changes in the area of pharmaceutical law, reimbursement and intellectual property law, and to present their opin- ions in the assessment of medical device regula- tions. They are also invited to contribute to the work of pharmaceutical business associations and parlia- mentary committees, and to attend conferences and academic debates and give lectures on postgraduate courses.

Authors

Marta Sroka-Maleta is co-managing partner of DBS Law Firm and an attorney-at-law (pol. radca prawny). For 20 years, she has been providing legal services for companies active in the pharmaceutical sector, focusing

Andrzej Siwiec is a partner at DBS Law Firm and an attorney-at-law (pol. radca prawny). He has more than a decade of experience and focuses on

medical and pharmaceutical law, including regulatory, market access, IP pharma and business development projects. He has authored publications on medical and pharmaceutical law and is a highly valued speaker at life sciences events, in addition to participating in work on legislative changes in pharmaceutical and reimbursement law. Andrzej has particular experience in international projects, and regularly manages work of other law firms in foreign jurisdictions. He is a member of the Cracow Bar Association.

on regulatory and reimbursement law, business development projects and intellectual property law, including patent litigation. She is often invited to participate in work on legislative changes in pharmaceutical law, reimbursement and industrial property law. Marta is a member of the Warsaw Bar Association and an active member of the IP Working Group of the generic association Medicines for Poland (PZPPF), representing the 18 largest Polish pharmaceutical producers.

250 CHAMBERS.COM

Powered by